Heranba Industries [HERANBA] vs Astec LifeSciences [ASTEC] Detailed Stock Comparison

Heranba Industries Ltd.

NSE
Loading...

Astec LifeSciences Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Heranba Industries Ltd. wins in 13 metrics, Astec LifeSciences Ltd. wins in 5 metrics, with 0 ties. Heranba Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Heranba Industries Ltd. Astec LifeSciences Ltd. Better
P/E Ratio (TTM) 417.08 399.52 Astec LifeSciences Ltd.
Price-to-Book Ratio 1.05 3.85 Heranba Industries Ltd.
Debt-to-Equity Ratio 60.27 88.61 Heranba Industries Ltd.
PEG Ratio 3.26 -6.22 Heranba Industries Ltd.
EV/EBITDA 19.66 -438.01 Heranba Industries Ltd.
Profit Margin (TTM) -3.73% -21.82% Heranba Industries Ltd.
Operating Margin (TTM) -4.39% -5.80% Heranba Industries Ltd.
Return on Equity 0.36% -57.34% Heranba Industries Ltd.
Return on Assets (TTM) 0.17% -15.29% Heranba Industries Ltd.
Free Cash Flow (TTM) $-1.75B $-302.21M Astec LifeSciences Ltd.
Dividend Yield 0.31% N/A N/A
1-Year Return -31.57% -2.45% Astec LifeSciences Ltd.
Price-to-Sales Ratio (TTM) 0.54 4.03 Heranba Industries Ltd.
Enterprise Value $13.59B $19.14B Astec LifeSciences Ltd.
EV/Revenue Ratio 0.84 4.68 Heranba Industries Ltd.
Gross Profit Margin (TTM) 36.31% 33.52% Heranba Industries Ltd.
Revenue per Share (TTM) $402 $197 Heranba Industries Ltd.
Earnings per Share (Diluted) $-15.01 $-42.30 Heranba Industries Ltd.
Beta (Stock Volatility) 0.25 -0.14 Astec LifeSciences Ltd.

Heranba Industries Ltd. vs Astec LifeSciences Ltd. Stock Performance Analysis

Loading Price Chart...

HERANBA
ASTEC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Heranba Industries Ltd.0.37%9.83%-7.31%10.47%-20.47%-22.13%
Astec LifeSciences Ltd.-0.86%-1.08%12.90%31.49%7.36%7.59%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Heranba Industries Ltd.-31.57%-52.58%-73.51%-76.76%-76.76%-76.76%
Astec LifeSciences Ltd.-2.45%-44.10%-40.21%167.45%1,600.77%832.28%

Performance & Financial Health Analysis: Heranba Industries Ltd. vs Astec LifeSciences Ltd.

MetricHERANBAASTEC
Market Information
Market Cap i₹8.72B₹16.36B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i133,103697,995
90 Day Avg. Volume i105,851413,508
Last Close₹189.57₹762.95
52 Week Range₹155.38 - ₹403.70₹513.40 - ₹998.40
% from 52W High-53.04%-23.58%
All-Time High₹945.00 (Mar 01, 2021)₹2,288.80 (Nov 14, 2022)
% from All-Time High-79.94%-66.67%
Growth Metrics
Quarterly Revenue Growth-0.12%0.33%
Quarterly Earnings GrowthN/A0.27%
Financial Health
Profit Margin (TTM) i-0.04%-0.22%
Operating Margin (TTM) i-0.04%-0.06%
Return on Equity (TTM) i0.00%-0.57%
Debt to Equity (MRQ) i60.2788.61
Cash & Liquidity
Book Value per Share (MRQ)₹209.04₹192.33
Cash per Share (MRQ)₹10.05₹4.35
Operating Cash Flow (TTM) i₹-1,237,700,000₹-705,500,000
Levered Free Cash Flow (TTM) i₹30.70M₹-1,347,524,000
Dividends
Last 12-Month Dividend Yield i0.31%N/A
Last 12-Month Dividend i₹1.00₹0.00

Valuation & Enterprise Metrics Analysis: Heranba Industries Ltd. vs Astec LifeSciences Ltd.

MetricHERANBA (Apr 24, 2026)ASTEC (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i417.08399.52
Forward P/E iN/A47.17
PEG Ratio i3.26-6.22
Price to Sales (TTM) i0.544.03
Price to Book (MRQ) i1.053.85
Market Capitalization
Market Capitalization i₹8.72B₹16.36B
Enterprise Value i₹13.59B₹19.14B
Enterprise Value Metrics
Enterprise to Revenue i0.844.68
Enterprise to EBITDA i19.66-438.01
Risk & Other Metrics
Beta i0.25-0.14
Book Value per Share (MRQ) i₹209.04₹192.33

Financial Statements Comparison: Heranba Industries Ltd. vs Astec LifeSciences Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricHERANBA (2025)ASTEC (2025)
Revenue/Sales i14.02B3.81B
Cost of Goods Sold i9.83B3.03B
COGS % of Revenue i70.1%79.4%
Gross Profit i4.19B785.91M
Gross Margin i29.9%20.6%
Research & Development i17.90M21.36M
Operating Income (EBIT) i413.60M-1.10B
Operating Margin i2.9%-28.8%
EBITDA i1.00B-636.39M
EBITDA Margin i7.2%-16.7%
Pre-Tax Income i180.60M-1.41B
Pre-Tax Income % of Revenue i1.3%-37.0%
Income Tax i158.10M-62.78M
Income Tax % of Revenue i1.1%-1.6%
Net Income (Profit) i22.50M-1.35B
Profit Margin i0.2%-35.3%

Balance Sheet & Liquidity Metrics

MetricHERANBA (2025)ASTEC (2025)
Cash & Equivalents i424.60M5.75M
Total Current Assets i10.33B3.41B
Total Current Assets % of Revenue i73.6%89.5%
Total Current Liabilities i8.60B3.66B
Total Current Liabilities % of Revenue i61.3%95.9%
Long-Term Debt i959.80M2.80B
Long-Term Debt % of Revenue i6.8%73.4%
Total Shareholders Equity i8.50B2.35B
Retained Earnings i6.93B1.41B
Retained Earnings % of Revenue i49.4%37.0%
Property, Plant & Equipment i710.60M317.38M

Cash Flow Statement Comparison

MetricHERANBA (2025)ASTEC (2025)
Operating Cash Flow i-1.24B-705.50M
Operating Cash Flow % of Revenue i-8.8%-18.5%
Capital Expenditures i-2.38B-158.54M
Free Cash Flow i-1.75B-302.21M
FCF Margin i-12.5%-7.9%
Debt Repayment iN/A-607.61M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricHERANBAASTEC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i40.01M22.28M
Float Shares i9.55M5.22M
% Held by Insiders i74.94%73.37%
% Held by Institutions i0.00%3.02%
% Held by Public i25.06%23.61%

Dividend Analysis & Yield Comparison: Heranba Industries Ltd. vs Astec LifeSciences Ltd.

MetricHERANBAASTEC
Last 12-Month Dividend i₹1.00₹0.00
Last 12-Month Dividend Yield i0.31%N/A
3-Year Avg Annual Dividend i₹1.17₹1.00
3-Year Avg Dividend Yield i0.31%0.10%
3-Year Total Dividends i₹3.50₹3.00
Ex-Dividend DateSep 17, 2025Jul 21, 2023